Guanghai Dai

2.7k citations
34 papers · 448 indexed · h-index 13
Topics
Colorectal Cancer Treatments and Studies (15 papers)Cancer Immunotherapy and Biomarkers (10 papers)Gastric Cancer Management and Outcomes (10 papers)
Partner nations
ChinaAustraliaThailand

In The Last Decade

Guanghai Dai

32 papers receiving 447 citations

Peers

Guanghai Dai
Comparison fields: 5 of 55
  • Oncology 355
  • Pulmonary and Respiratory Medicine 128
  • Surgery 122
  • Molecular Biology 63
  • Immunology 60
Replace Vito Longo with:
Vito Longo Italy
Chuanhua Zhao China
Xianhe Xie China
Zhefeng Liu China
Matthew Chau Hsien Ng Singapore
Guoqiang Wang China
Nishi Kothari United States
Gerry Gin Wai Kwok China
Shivani Handa United States
Elaine Tan United States
Guanghai Dai relative to Vito Longo Italy Vito Longo's profile →
Citations per field
00.5×1.5×2.3×
Vito Longo · 1×
Citations per year

Countries citing papers authored by Guanghai Dai

Since Specialization
Citations

This map shows the geographic impact of Guanghai Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanghai Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanghai Dai more than expected).

Fields of papers citing papers by Guanghai Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanghai Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanghai Dai. The network helps show where Guanghai Dai may publish in the future.

Co-authorship network of co-authors of Guanghai Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Guanghai Dai. A scholar is included among the top collaborators of Guanghai Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanghai Dai. Guanghai Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 5
5 1
6 10
7 26
8 15
9 17
10 6
11 19
12 32
13 27
14 5
15 33
16 11
17 12
18 13
19 1
20 4

About Guanghai Dai

Guanghai Dai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 34 papers that have together received 448 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Gastric Cancer Management and Outcomes (10 papers). The work is most often cited by research in Oncology (355 citations), Hepatology (33 citations) and Pulmonary and Respiratory Medicine (128 citations). Guanghai Dai has collaborated with scholars based in China, Australia and Thailand. Frequent co-authors include Miaomiao Gou, Zhikuan Wang, Haiyan Si, Niansong Qian, Huan Yan, Yong Zhang, Chuan Tong, Chunmeng Wang, Wenbin Qian and Jianshu Wei. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Cochrane Database of Systematic Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026